ProFibrix Completes Patient Enrolment in Pivotal Phase III With Fibrocaps™ and Reports Positive Feedback From Surgical Community
4/4/2013 11:43:38 AM
More...
|
ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase 3 With Fibrocaps™ and Successfully Concludes Safety Review Assessment
11/8/2012 10:21:43 AM
More...
|
ProFibrix to Present FibrocapsTM Phase II Data & Progress in Recombinant Fibrinogen Program at International Conferences
7/5/2012 10:54:59 AM
More...
|
ProFibrix US Phase II Study with FibrocapsTM Meets All Primary and Secondary Endpoints
1/5/2012 6:16:37 AM
More...
|
ProFibrix Phase II with FibrocapsTM Meets Primary Endpoint – On Track for Phase III in 2012
11/15/2011 6:18:44 AM
More...
|
ProFibrix Completes Enrollment of Phase II Studies with Lead Hemostasis Product FibrocapsTM and Targets Start of Phase III in H1 2012
9/13/2011 10:18:25 AM
More...
|
ProFibrix Raises $22M to Progress Fibrocaps Topical Sealant into Phase III
5/4/2011 8:29:10 AM
More...
|
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer
3/11/2010 8:21:09 AM
More...
|
ProFibrix Obtains Government Loan of up to $7.4 Million to Support Clinical Development of its Lead Hemostasis Product Fibrocaps(TM)
1/7/2010 8:57:36 AM
More...
|
ZymoGenetics, Inc. (ZGEN)'s Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
10/26/2009 7:56:50 AM
More...
|
|